Profile photo Karin van Galen

Karin van Galen

Assistant Professor - medical

Strategic program(s):

Biography

After graduating in medicine, Mrs. Karin van Galen was trained in the field of internal medicine. She completed her specialisation as a hematologist in 2011 after which she was appointed as Consultant Hematologist at the Department Van Creveldkliniek of the UMC Utrecht. Here she has expanded her clinical experience in the treatment of patients with benign hematological conditions. In addition to patient care Karin van Galen finished a PhD project on joint bleeding in Von Willebrand disease in November 2017 and currently participates in several (inter)national studies on congenital bleeding disorders. She runs post-doc research on pregnancy in inherited bleeding disorders and heavy menstrual bleeding in adolescents, (co)supervises PhD students and is a well-known (inter)national advocate for women and girls with inherited bleeding disorders

Research groups

Hemophilia, Von Willebrand disease and allied coagulation disorders

Research aim

To improve care for patients with (inherited) bleeding disorders by studying the optimum outcome parameters in a multidisciplinary setting, including physiotherapy and nursing interventions, as well as novel treatment modalities.

Go to group

Recent publications

Limited value of testing for factor XIII and α2-antiplasmin deficiency in patients with a bleeding disorder of unknown cause Sander Ariëns, Albert Huisman, Idske C L Kremer Hovinga, Rolf T Urbanus, Karin P M van Galen, Lize F D van Vulpen, Kathelijn Fischer, Roger E G Schutgens
Haemophilia, 2024, vol. 30, p.998-1002
Heavy menstrual bleeding in adolescents Stella J. Van ‘t Klooster, Anne de Vaan, Jeanette van Leeuwen, Lynnda Pekel, Nathalie M. van Rijn-van Kortenhof, Eveline T. Engelen, Willie van Greevenbroek, Albert Huisman, Kathelijn Fischer, Roger E.G. Schutgens, Karin P.M. van Galen
Research and practice in thrombosis and haemostasis, 2023, vol. 7
Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment—a prospective cohort study Wobke E.M. van Dijk, Geke C. Poolen, Albert Huisman, Harry R. Koene, Rob Fijnheer, Noortje Thielen, Esther R. van Bladel, Karin P.M. van Galen, Roger E.G. Schutgens, Rolf T. Urbanus
Journal of Thrombosis and Haemostasis, 2023, vol. 21, p.1020-1031
Clotting factor activity levels and bleeding risk in people with haemophilia playing sports Olav Versloot, Ellen Kemler, Johan Blokzijl, Merel Timmer, Marleen Schuuring, Karin P.M. van Galen, Idske Cornelia L. Kremer Hovinga, Paul R. van der Valk, Lize F.D. van Vulpen, Roger E.G. Schutgens, Casper F. van Koppenhagen, Janjaap van der Net, Kathelijn Fischer
Haemophilia, 2023, vol. 29, p.1013-1023
Can motor proficiency testing predict sports injuries and sports-induced bleeds in people with haemophilia? Olav Versloot, Johan Blokzijl, Merel Timmer, Marleen Schuuring, Karin van Galen, Idske Kremer Hovinga, Paul van der Valk, Lize van Vulpen, Roger Schutgens, Casper van Koppenhagen, Janjaap van der Net, Kathelijn Fischer
Haemophilia, 2023, vol. 29, p.864-873
Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder Wala Al Arashi, Lorenzo G R Romano, Frank W G Leebeek, Marieke J H A Kruip, Karin P M van Galen, Ozlem Turan, Rezan Abdul Kadir, Marjon H Cnossen,
Journal of thrombosis and haemostasis : JTH, 2023, vol. 22, p.126-139